Abstract
PURPOSEMetastatic prostate cancer is initially sensitive to androgen receptor inhibition, but eventually becomes castration-resistant prostate cancer (mCRPC). Early use of more intensive therapies ...
Cite
CITATION STYLE
APA
Einstein, D. J., Arai, S., Calagua, C., Xie, F., Voznesensky, O., Capaldo, B. J., … Russo, J. W. (2021). Metastatic Castration-Resistant Prostate Cancer Remains Dependent on Oncogenic Drivers Found in Primary Tumors. JCO Precision Oncology, (5), 1514–1522. https://doi.org/10.1200/po.21.00059
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free